Conte P - Search Results

1

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).

Jerusalem G, Mariani G, Ciruelos EM, Martin M, Tjan-Heijnen VC, Neven P, Gavila JG, Michelotti A, Montemurro F, Generali D, Simoncini E, Lang I, Mardiak J, Naume B, Camozzi M, Lorizzo K, Bianchetti S, Conte P. Jerusalem G, et al. Among authors: conte p. Ann Oncol. 2016 Sep;27(9):1719-25. doi: 10.1093/annonc/mdw249. Epub 2016 Jun 29. Ann Oncol. 2016. PMID: 27358383 Free article. Clinical Trial.

2

Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications.

Valenti M, Cimoli G, Parodi S, Mariani GL, Venturini M, Conte P, Russo P. Valenti M, et al. Among authors: conte p. Eur J Cancer. 1993;29A(8):1157-61. doi: 10.1016/s0959-8049(05)80307-7. Eur J Cancer. 1993. PMID: 8518027

3

Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.

Michelotti A, Romanini A, Giannessi P, Bengala C, Conte P. Michelotti A, et al. Among authors: conte p. Am J Clin Oncol. 1996 Feb;19(1):78-81. doi: 10.1097/00000421-199602000-00016. Am J Clin Oncol. 1996. PMID: 8554042 Clinical Trial.

4

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

Nabholtz JM, Gelmon K, Bontenbal M, Spielmann M, Catimel G, Conte P, Klaassen U, Namer M, Bonneterre J, Fumoleau P, Winograd B. Nabholtz JM, et al. Among authors: conte p. J Clin Oncol. 1996 Jun;14(6):1858-67. doi: 10.1200/JCO.1996.14.6.1858. J Clin Oncol. 1996. PMID: 8656254 Clinical Trial.

5

Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.

Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P. Baldini E, et al. Among authors: conte p. Semin Oncol. 2000 Feb;27(1 Suppl 1):28-32. Semin Oncol. 2000. PMID: 10697041 Clinical Trial.

6

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.

Michelotti A, Venturini M, Tibaldi C, Bengala C, Gallo L, Carnino F, Del Mastro L, Lionetto R, Montanaro E, Rosso R, Conte P. Michelotti A, et al. Among authors: conte p. Breast Cancer Res Treat. 2000 Jan;59(2):133-9. doi: 10.1023/a:1006394801389. Breast Cancer Res Treat. 2000. PMID: 10817348 Clinical Trial.

7

The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.

Conte P, Salvadori B, Donati S, Gennari A, Cetto GL, Molino A, Crino L, Mazzoni F, Galligioni E, Mansutti M. Conte P, et al. Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):41-3. Oncology (Williston Park). 2001. PMID: 11252889 Clinical Trial.

8

5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

Falcone A, Allegrini G, Masi G, Lencioni M, Pfanner E, Brunetti I, Danesi R, Bocci G, Del Tacca M, Conte P. Falcone A, et al. Among authors: conte p. Oncology. 2001;61(1):28-35. doi: 10.1159/000055349. Oncology. 2001. PMID: 11474245 Clinical Trial.

9

Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).

Di Costanzo F, Sobrero A, Gasperoni S, Dogliotti L, Frassineti L, Falcone A, Lionetto R, Bruzzi P, Luppi G, Gallo L, Conte P, Comandone A, Turci D, Marzola M, Folco U, Pfanner E, Mestriner M, Boni C, Galli C, Tonato M, Rosso R; Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Di Costanzo F, et al. Among authors: conte p. Ann Oncol. 2003 Sep;14(9):1365-72. doi: 10.1093/annonc/mdg359. Ann Oncol. 2003. PMID: 12954574 Free article. Clinical Trial.

10

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy.

Guarneri V, Piacentini F, Ficarra G, Frassoldati A, D'Amico R, Giovannelli S, Maiorana A, Jovic G, Conte P. Guarneri V, et al. Among authors: conte p. Ann Oncol. 2009 Jul;20(7):1193-8. doi: 10.1093/annonc/mdn761. Epub 2009 Feb 16. Ann Oncol. 2009. PMID: 19221152 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page